Tirzepatide benefits people with obesity, kidney disease and heart failure

Tirzepatide benefits people with obesity, kidney disease and heart failure

Source: Medical Xpress

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured clinical research presented at the American College of Cardiology's Annual Scientific Session (ACC.25) and simultaneously published in JACC.

This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Credit: Unsplash/CC0 Public Domain
The drug tirzepatide improved kidn… [4887 chars]

Read more